title: 'Opioid drought', Canadian-style? Potential implications of the 'natural experiment' of delisting oxycontin in Canada.
authors.affiliation: Centre for Applied Research in Mental Health and Addictions, Faculty of Health Sciences, Simon Fraser University, 2400, 515 West Hastings St., Vancouver, BC, Canada. bfischer@sfu.ca
authors.forename: Benedikt
authors.initials: B
authors.lastname: Fischer
authors.forename: Annette
authors.initials: A
authors.lastname: Keates
mesh_terms: D000701:Analgesics, Opioid / Q000600:supply & distribution*; D002170:Canada / Q000453:epidemiology; D002391:Catchment Area, Health; D002626:Chemistry, Pharmaceutical; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D033161:Government Regulation; D040261:Harm Reduction; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D013287:Illicit Drugs / Q000600:supply & distribution*; D009293:Opioid-Related Disorders / Q000401:mortality / Q000517:prevention & control*; D010098:Oxycodone / Q000031:analogs & derivatives / Q000737:chemistry / Q000600:supply & distribution*; D010602:Pharmacopoeias as Topic
chemical_list: D000701:Analgesics, Opioid; D013287:Illicit Drugs; D010098:Oxycodone